OTC Markets OTCPK - Delayed Quote USD

Getinge AB (publ) (GNGBF)

Compare
20.13 0.00 (0.00%)
At close: October 25 at 4:00 PM EDT
Loading Chart for GNGBF
DELL
  • Previous Close 0.00
  • Open 21.95
  • Bid 17.75 x 40700
  • Ask 19.85 x 38800
  • Day's Range 21.55 - 21.95
  • 52 Week Range 17.44 - 22.39
  • Volume 200
  • Avg. Volume 34
  • Market Cap (intraday) 5.116B
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) 34.12
  • EPS (TTM) 0.59
  • Earnings Date Oct 18, 2024
  • Forward Dividend & Yield 0.40 (2.00%)
  • Ex-Dividend Date Apr 23, 2024
  • 1y Target Est --

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, mechanical circulatory support, advanced patient monitoring, ICU infrastructure equipment, patient flow management, and drainage solutions. The company also provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, and drainage solutions; and operating room infrastructure equipment, anesthesia, advanced patient monitoring, operating room management, and operating room integration solutions. In addition, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices; bioreactor systems, DPTE systems, Getinge isolators, terminal sterilization products, and sterilizers; and vivarium, biohazardous materials handling solutions, labware cleaning and sterilization, upstream bioprocessing, and bioreactor preparation solutions. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

www.getinge.com

11,848

Full Time Employees

December 31

Fiscal Year Ends

Recent News: GNGBF

View More

Performance Overview: GNGBF

Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

GNGBF
7.39%
OMX Stockholm 30 Index
8.09%

1-Year Return

GNGBF
15.45%
OMX Stockholm 30 Index
24.98%

3-Year Return

GNGBF
55.67%
OMX Stockholm 30 Index
10.36%

5-Year Return

GNGBF
43.89%
OMX Stockholm 30 Index
49.24%

Compare To: GNGBF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: GNGBF

View More

Valuation Measures

Annual
As of 10/25/2024
  • Market Cap

    5.12B

  • Enterprise Value

    5.93B

  • Trailing P/E

    34.30

  • Forward P/E

    18.45

  • PEG Ratio (5yr expected)

    1.58

  • Price/Sales (ttm)

    1.73

  • Price/Book (mrq)

    1.92

  • Enterprise Value/Revenue

    1.87

  • Enterprise Value/EBITDA

    12.15

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.03%

  • Return on Assets (ttm)

    3.77%

  • Return on Equity (ttm)

    5.45%

  • Revenue (ttm)

    33.59B

  • Net Income Avi to Common (ttm)

    1.69B

  • Diluted EPS (ttm)

    0.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.24B

  • Total Debt/Equity (mrq)

    35.67%

  • Levered Free Cash Flow (ttm)

    3.86B

Research Analysis: GNGBF

View More

Company Insights: GNGBF

Research Reports: GNGBF

View More

People Also Watch